跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49 条关于
“LongBio”
全部
49
临床试验
11
药物
25
机构
5
资讯
8
3个月前
LongBio Pharma Debuts on Hong Kong Stock Exchange at HK$10.7 Billion Valuation, Advancing Novel Anti-IgE and Complement-Targeting Biologics
去年
LongBio's LP-003 Receives IND Approval in China for Food Allergy Treatment
4天前
China NMPA Accepts BLA for LongBio's Anti-IgE Antibody LP-003 in Seasonal Allergic Rhinitis
6个月前
LongBio's LP-003 Demonstrates Superior Efficacy Over Xolair in Phase II Chronic Urticaria Trial
去年
Novel Anti-IgE Antibody LP-003 Shows Superior Efficacy Over Omalizumab in Chronic Spontaneous Urticaria Trial
去年
Urticaria Clinical Trial Pipeline Heats Up with Novel Therapies in Development
3个月前
LeonaBio Unveils Phase 2 Plans for Brelgometon (ATH-1105) in ALS, Highlighting Biomarker-Driven Trial Design at Summit
上个月
LeonaBio On Track to Complete Phase 3 ELAINE-3 Enrollment for Lasofoxifene in ESR1-Mutated Metastatic Breast Cancer in 4Q 2026